Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York.
| Revenue (TTM) | $1.09B |
| Gross Profit (TTM) | $605.91M |
| EBITDA | $340.68M |
| Operating Margin | 26.80% |
| Return on Equity | 10.20% |
| Return on Assets | 5.61% |
| Revenue/Share (TTM) | $22.47 |
| Book Value | $38.66 |
| Price-to-Book | 1.21 |
| Price-to-Sales (TTM) | 2.09 |
| EV/Revenue | 3.0 |
| EV/EBITDA | 9.86 |
| Quarterly Earnings Growth (YoY) | 12.40% |
| Quarterly Revenue Growth (YoY) | -5.00% |
| Shares Outstanding | $47.37M |
| Float | $46.76M |
| % Insiders | 1.41% |
| % Institutions | 113.56% |
Volatility is currently expanding